Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 22Breast Neoplasms 18Hematologic Neoplasms 16Colorectal Neoplasms 13Prostatic Neoplasms 11Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Pancreatic Neoplasms 9Hematopoietic and Lymphatic System Neoplasm 9Anatomic Stage I Breast Cancer AJCC v8 9Urinary Bladder Neoplasms 6Ovarian Neoplasms 6Neoplasm Metastasis 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Multiple Myeloma 5Leukemia, Myeloid, Acute 5Head and Neck Carcinoma 5Breast Carcinoma In Situ 5Triple Negative Breast Neoplasms 4Stomach Neoplasms 4Melanoma 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Rectal Neoplasms 3Myelodysplastic Syndromes 3Mouth Neoplasms 3Malignant Solid Neoplasm 3Lymphoma 3

Interventions

vandetanib 12cabozantinib 8selpercatinib 5Sorafenib 5Everolimus 5Magnetic Resonance Spectroscopy 3Capecitabine 3sargramostim 2pralsetinib 2lutetium Lu 177 dotatate 2lenvatinib 2Trastuzumab 2Temozolomide 2Sunitinib 2Specimen Handling 2Octreotide 2High-Energy Shock Waves 2Gefitinib 2Doxorubicin 2yeast-CEA vaccine 1veliparib 1vatalanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1temsirolimus 1tanespimycin 1sacubitril and valsartan sodium hydrate drug combination 1rovalpituzumab tesirine 1ponatinib 1pentetreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Medullary × Practice Guidelines as Topic × Clear all
NCT04467021 2026-05-06

Cancer and Blood Pressure Management, CARISMA Study

Eastern Cooperative Oncology Group

Phase NA Active not recruiting
61 enrolled
Genitourinary

Carcinoma, Renal Cell, Cardiovascular Diseases, Carcinoma, Medullary, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡